D01.0

Clinical Causes: Genetic mutations affecting cell growth and division Chronic inflammatory conditions of the colon, such as ulcerative colitis or Crohn's disease Dietary factors, including high consumption of processed and red meats Lifestyle factors like smoking and excessive alcohol intake Age-related cellular changes in the colon lining Certain hereditary syndromes, such as familial adenomatous polyposis or Lynch syndrome

Key Symptoms: Often asymptomatic in early stages, making detection challenging Occasional rectal bleeding or blood in stool Changes in bowel habits, such as diarrhea or constipation Unexplained abdominal discomfort or cramping A feeling of incomplete bowel evacuation Unintentional weight loss in some cases

Diagnosis Path: Diagnosis typically involves a combination of colonoscopic examinations and histopathological analysis. During a colonoscopy, abnormal areas within the colon lining can be visually identified and biopsied. The biopsy specimen is examined microscopically to confirm the presence of carcinoma in situ, characterized by abnormal cells confined to the epithelial layer without invasion into deeper tissues. Additional diagnostic tools may include imaging studies like CT scans, to evaluate the extent of disease and rule out spread, although in carcinoma in situ, invasion is absent by definition.

Treatment Protocols: The primary treatment option for carcinoma in situ of the colon involves removal of the abnormal tissue. This can often be achieved through minimally invasive procedures such as polypectomy or endoscopic mucosal resection during a colonoscopy. In some cases, surgical removal of a portion of the colon may be necessary, especially if multiple lesions are present or there is suspicion of deeper invasion. Regular follow-up colonoscopies are essential to monitor for recurrence or development of new lesions. Preventive strategies, including dietary modifications and lifestyle changes, are also recommended to reduce the risk of progression to invasive cancer.